‡ In these countries please contact our distributor

Iodosorb* Product in use

This information is intended for Healthcare Professionals only.


“The effect of Cadexomer iodine on pain and its ease of application and removal gave high acceptance by patients and nurses” 17

Considering an Appropriate Topical Antimicrobial Treatment


The importance of wound infections, in both economic and human terms, should not be underestimated. Recognising and managing the signs and consequences of clinically infected wounds is key to preventing a delay in healing.

The infection continuum, as described by Kingsley 20 is a model by which clinicians can define and assess wounds.


Antimicrobial dressings should be used when the wound is showing signs of critical colonisation or infection or is at risk of becoming infected. A wound may be at risk because of its location, the surrounding environment or other pre-determined risk.

The table below gives an indication of when an antimicrobial dressing would be appropriate.


Contamination Colonised

Critically Colonised


Coloured arrow


The host is in control; antimicrobial activity is not required. There are no visual signs of infection. Allevyn* or Opsite* Post-Op dressings can be used to manage moisture balance, and a specific choice should be made depending on the level of exudate. Cleansing of the wound bed may be required, to remove any debris, through mechanical or autolytic debridement techniques. The host remains in control; antimicrobial activity is not required.
These wounds are characterised by the presence of bacteria without the typical clinical signs of wound infection. Exudate levels are generally low to moderate. Allevyn or Opsite Post -Op dressings can be used to manage moisture balance, and a specific choice should be made depending on the level of exudate.
The host is no longer in control.An antimicrobial dressing may therefore be necessary. The wound may appear to be in transition, not responding to the wound care regime, yet there are no specific signs/ systems of clinical wound infection. Pain is often exacerbated or present where it has not been before Exudate levels are likely to be moderate to high and odour may be present. The wound bed typically contains a thick slough, Iodosorb can be used to manage the slough and exudate and reduce the bacterial burden.
The host is no longer in control. The wound and surrounding area is characterised by clinical signs and systems of infection such as erythema, cellulites, pain, swelling. Malodour is present, and exudate levels are usually high. The wound bed may contain necrotic or sloughy or friable granulation tissue, which bleeds easily. Systemic antibiotics should be used according to clinical protocol to treat the infection. Iodosorb can be used to manage the exudate and reduce the bacterial burden of the wound. This is important particularly if there are issues with blood perfusion.


NB Topical antimicrobials are used to reduce bio-burden; therefore, the choice has to be related to the identity of the causative organisms, assessed either through bacterial culture or clinical judgement. The choice of topical agent should also include an awareness of their potential to induce sensitisation.




Iodosorb Dressing

Iodosorb Dressing
more >


Iodosorb Ointment

Iodosorb Ointment
more >


Iodosorb Powder

Iodosorb Powder
more >





  • There is a potential risk of interaction with lithium, resulting in an increased possibility of hypothyroidism.
  • Do not use Iodosorb concomitantly with mercurial antiseptics or taurolidine.
  • If the patient is about to undergo thyroid function tests, they should inform the doctor.




  • The contents of the tube/sachet/pot should be used on one patient only.
  • Do not use Iodosorb in the vicinity of the eyes, ears, nose or mouth.
  • The product is for external use only.
  • Iodosorb may cause a slight transient pain in the first hour after treatment. This is a sign that the product is beginning to clean the wound. Occasionally, Iodosorb may cause the skin around the wound edges to swell or redden. This will usually pass. If these symptoms persist or if the patient experiences any other symptoms, they should contact the doctor or nurse.
  • Contact with the skin around the wound edges/intact skin should be minimised.
  • It is possible for an adherent crust to form if the Iodosorb is allowed to dry out.
  • A single application of Iodosorb should not exceed 50g and not more than 150g in one week.
  • The duration of treatment should not exceed 3 months.




  • Do not use on dry necrotic tissue, or on patients with a known sensitivity to Iodine or any of the other components.
  • Do not use on children, pregnant or lactating women or people with renal impairment or thyroid disorders (e.g. Hashimoto's thyroiditis or non-toxic nodular goitre).




more >